There is a risk to patients with latex allergy related to the use of the trivalent influenza vaccine Fluad, the TGA warns
Consumers and health professionals are advised that, for the 2018 influenza season, natural rubber latex is present in the sheath covering the needle of trivalent influenza vaccine Fluad.
Fluad is available for people aged 65 years and over through the National Immunisation Program (NIP).
While reactions to latex are rare, anyone who has a severe allergy to latex should not receive Fluad, warns the TGA.
However it says patients 65 and over can still be safely vaccinated with an alternative trivalent influenza vaccine, Fluzone High-Dose, through the NIP.
“If you are vaccinating patients with Fluad, please be aware of this issue and advise patients accordingly. Reassure patients that reactions to latex are rare,” says the TGA.
“Please note there are no safety concerns regarding the vaccine itself.
“Before administering Fluad, confirm with patients that they are not allergic to latex.
“As with all vaccinations, be prepared to treat immediate allergic reactions, including potential anaphylaxis.”
The sponsor of Fluad, Seqirus, has reportedly committed to updating the Product Information of this vaccine accordingly.
If you have any questions or concerns about this issue, contact Seqirus on 1800 642 865.